CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-09-03 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +15,026 | $15.50 | $233K | 59,543 |
| 2025-09-03 | Tessari Eben CHIEF OPERATING OFFICER | Sale 10b5-1 | −15,091 | $35.50 | $536K | 44,452 |
| 2025-09-03 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −65 | 59,935 | ||
| 2025-09-03 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Share Option 10b5-1 | −15,026 | 44,974 | ||
| 2025-09-03 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +11,000 | $17.92 | $197K | 49,011 |
| 2025-09-03 | Megna Michael R CHIEF ACCOUNTING OFFICER | Sale 10b5-1 | −11,000 | $34.84 | $383K | 38,011 |
| 2025-09-03 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Share Option 10b5-1 | −11,000 | 0 | ||
| 2025-09-02 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise 10b5-1 | +1,964 | 45,402 | ||
| 2025-09-02 | Tessari Eben CHIEF OPERATING OFFICER | Shares withheld for taxes 10b5-1 | −950 | $34.28 | $33K | 44,452 |
| 2025-09-02 | Tessari Eben CHIEF OPERATING OFFICER | Option exercise · Restricted Share Unit 10b5-1 | −1,964 | 0 | ||
| 2025-09-02 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise 10b5-1 | +774 | 38,386 | ||
| 2025-09-02 | Megna Michael R CHIEF ACCOUNTING OFFICER | Shares withheld for taxes 10b5-1 | −375 | $34.28 | $13K | 38,011 |
| 2025-09-02 | Megna Michael R CHIEF ACCOUNTING OFFICER | Option exercise · Restricted Share Unit 10b5-1 | −774 | 0 | ||
| 2025-09-02 | Moat Ross CHIEF CORP. & COMM. OFFICER | Option exercise | +994 | 13,419 | ||
| 2025-09-02 | Moat Ross CHIEF CORP. & COMM. OFFICER | Shares withheld for taxes | −481 | $34.28 | $16K | 12,938 |
| 2025-09-02 | Moat Ross CHIEF CORP. & COMM. OFFICER | Option exercise · Restricted Share Unit | −994 | 0 | ||
| 2025-09-02 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise | +1,725 | 62,159 | ||
| 2025-09-02 | Paolini John F. CHIEF MEDICAL OFFICER | Shares withheld for taxes | −835 | $34.28 | $29K | 61,324 |
| 2025-09-02 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Restricted Share Unit | −1,725 | 0 | ||
| 2025-09-02 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise | +1,861 | 31,986 |
Page 23 of 74 · 1,467 trades